Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patterns of Real-World Isavuconazole Use, Effectiveness, Safety, and Healthcare Resource Utilization-a Retrospective Chart Review Study of Patients With Mucormycosis or Invasive Aspergillosis (PRISMA)

NCT04550936 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04550936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04550936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patterns of Real-World Isavuconazole Use, Effectiveness, Safety, and Healthcare Resource Utilization-a Retrospective Chart Review Study of Patients With Mucormycosis or Invasive Aspergillosis (PRISMA)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 10, 2021
Completion date
December 23, 2023
Enrollment
307 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

invasive aspergillosis, mucormycosis